Skip to main content

Articles

Page 1 of 9

  1. A multi-criteria decision analysis (MCDA) approach has been suggested for helping purchasers in low- and middle-income countries in an evidence-based assessment of multi-source pharmaceuticals to mitigate pote...

    Authors: Anke-Peggy Holtorf, Erna Kristin, Anunchai Assamawakin, Nilawan Upakdee, Rina Indrianti and Napassorn Apinchonbancha

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:52

    Content type: Research

    Published on:

  2. Lebanon, a developing Middle Eastern country, was hit by the COVID-19 pandemic that occurred amid a severe national economic crisis. Community pharmacists are responsible for dispensing appropriate medications...

    Authors: Rony M. Zeenny, Ahmad Dimassi, Hala Sacre, Ghada El Khoury, Aline Hajj, Rita Farah, Hind Hajj, Nathalie Lahoud, Marwan Akel, Souheil Hallit and Pascale Salameh

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:51

    Content type: Research

    Published on:

  3. People living with diabetes are more vulnerable to drug-related problems due to the presence of multiple diseases. This study aimed to identify drug-related problems and contributing factors among diabetic pat...

    Authors: Tadesse Sheleme, Tamiru Sahilu and Desalegn Feyissa

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:50

    Content type: Research

    Published on:

  4. Globally, self-medication is a common practice, and an increasingly perceived necessity to relieve burdens on health services. However, inappropriate self-medication may result to reduced health outcomes, incr...

    Authors: Wuraola Akande-Sholabi, Amen. T. Ajamu and Rasaq Adisa

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:49

    Content type: Research

    Published on:

  5. Africa as a continent has experienced a continuous increase in the cost of healthcare as its demands increase. With many of these African countries living below the poverty threshold, Africans continue to die ...

    Authors: Temitope Ben-Ajepe, Ifechukwu Benedict Nwogu, Damilola Quazeem Olaoye, Abdulhafeez Ayodele Mustapha, Theogene Uwizeyimana and Yusuff Adebayo Adebisi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:47

    Content type: Commentary

    Published on:

  6. This research aimed to evaluate analgesic utilization in public hospitals from 2013 to 2018 by analyzing the procurement data of 793 hospitals in China.

    Authors: Honghao Shi, Xianwen Chen, Xueli Liu, He Zhu, Fei Yu, Carolina Oi Lam Ung, Wai Sin Chan, Hao Hu and Sheng Han

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:45

    Content type: Research

    Published on:

  7. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al‑Hemyari, Naseem Mohammed Abdulla, Faris El‑Dahiyat, Maimona Jairoun, Saleh Karamah AL‑Tamimi and Zaheer‑Ud‑Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:44

    Content type: Correction

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2021 14:38

  8. Adequate quality systems throughout pharmaceutical supply chains are crucial to protect individuals and communities from substandard and falsified medical products. Thus, pharmaceutical distributors are regula...

    Authors: Anthony Bourasseau, Laurine Lavergne and Raffaella Ravinetto

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:43

    Content type: Research

    Published on:

  9. Cardiovascular disease (CVD) is an emerging contributor to national morbidity and mortality in Saudi Arabia. CVD risk prevention services are limited, particularly with an over-utilised public health sector an...

    Authors: Hadi A. Almansour, Nouf M. Aloudah, Tariq M. Alhawassi, Betty Chaar, Ines Krass and Bandana Saini

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:42

    Content type: Research

    Published on:

  10. The implementation of pharmaceutical services in hospitals contributes to the appropriate use of medicines and patient safety. However, the relationship of implementation with the legal framework and organizat...

    Authors: Laura C. Vargas López, Fela Viso Gurovich, Anahí Dreser Mansilla, Veronika J. Wirtz and Michael R. Reich

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:41

    Content type: Research

    Published on:

  11. Over the last year, the dangerous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly around the world. Malaysia has not been excluded from this COVID-19 pandemic. The resurgence of...

    Authors: Ching Siang Tan, Saim Lokman, Yao Rao, Szu Hua Kok and Long Chiau Ming

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:40

    Content type: Commentary

    Published on:

  12. Proper hand hygiene using alcohol-based handrub (ABHR) is an effective preventive approach for the current Coronavirus Disease 2019 (COVID-19) pandemic and other infections. World Health Organization recommend...

    Authors: Muluken Nigatu Selam, Regasa Bayisa, Andualem Ababu, Mahdi Abdella, Edessa Diriba, Minychel Wale and Assefa Mulu Baye

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:39

    Content type: Research

    Published on:

  13. Since the WHO announced that Covid-19 had become a global pandemic, online pharmacies have emerged as an extremely popular way to purchase medication due to the quarantine measures introduced by numerous count...

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Naseem Mohammed Abdulla, Faris El-Dahiyat, Maimona Jairoun, Saleh Karamah AL-Tamimi and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:38

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2021 14:44

  14. We considered the extent of the contribution of publicly funded research to the late-stage clinical development of pharmaceuticals and medicinal products, based on the European Commission (EC) FP7 research fun...

    Authors: L. Schmidt, O. Sehic and C. Wild

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:37

    Content type: Research

    Published on:

  15. Drug-related problems (DRPs) can occur at any stages of medication use processes, and a single drug could be associated with multiple DRPs. Once happened, it adversely affects health outcomes. In Ethiopia, eva...

    Authors: Fuad Adem, Jemal Abdela, Dumessa Edessa, Bisrat Hagos, Abraham Nigussie and Mohammed A. Mohammed

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:36

    Content type: Review

    Published on:

  16. Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...

    Authors: Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George and Nikolaus Marx

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35

    Content type: Commentary

    Published on:

  17. In Nigeria, there is a prevalence of aversive life circumstances that frequently assail the mental health and well-being of the citizens, mitigating the impact of which necessitates the institution of psychoth...

    Authors: Adeboye Olakunle Bamgboye, Ibrahim Adebayo Hassan, Yusuff Adebayo Adebisi, Rachael Oluwatoyosi Farayola and Theogene Uwizeyimana

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:34

    Content type: Commentary

    Published on:

  18. Drug use evaluation is a structured, methodological, and criteria-based drug assessment system that helps to evaluate the actual trend of drug use in a particular setting. If drug prescription practices are in...

    Authors: Bereket Bahiru Tefera, Melese Getachew and Bekalu Kebede

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:31

    Content type: Review

    Published on:

  19. Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has r...

    Authors: Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico and Claudio Jommi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:30

    Content type: Research

    Published on:

  20. Insufficient access to quality, safe, efficacious and affordable medical products in Africa has posed a significant challenge to public health for decades. In part, this is attributed to weak or absent policie...

    Authors: Bakani Mark Ncube, Admire Dube and Kim Ward

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:29

    Content type: Commentary

    Published on:

  21. Monitoring adverse drug reactions is a vital issue to ensure drug safety and to protect the general public from medication-related harmful effects. In order to properly monitor drug safety, a regulatory system...

    Authors: Zuzaan Zulzaga, Erdenetuya Myagmarsuren, Herman J. Woerdenbag and Eugene P. van Puijenbroek

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:15

    Content type: Commentary

    Published on:

  22. Measuring access to medicines has often been limited to assessing availability and affordability, while little is known regarding other dimensions of access including geographical accessibility. Our study aims...

    Authors: Cindrel Tharumia Jagadeesan and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:28

    Content type: Review

    Published on:

  23. Self-care is one of the growing tasks of community pharmacy professionals. They are highly engaged in consultations in response to specific drug request (product-based presentation) or symptoms clients describ...

    Authors: Dawit Wondimsigegn, Berhanemeskel Woldegerima and Asefa Adimasu Taddese

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:26

    Content type: Research

    Published on:

  24. Increasingly, there has been recognition that siloed approaches focusing mainly on human health are ineffective for global antimicrobial resistance (AMR) containment efforts. The inherent complexities of AMR c...

    Authors: Mohan P. Joshi, Tamara Hafner, Gloria Twesigye, Antoine Ndiaye, Reuben Kiggundu, Negussu Mekonnen, Ndinda Kusu, Safoura Berthé, Edgar Peter Lusaya, Alphonse Acho, Robert Tuala Tuala, Ayasha Siddiqua, Henri Kaboré, Soukeyna Sadiya Aidara and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:27

    Content type: Research

    Published on:

  25. The COVID-19 pandemic has further strengthened the need for pharmacists to uptake non-traditional roles. Pharmacy practice in Saudi Arabia is emerging in recent years with greater policy emphasis on pharmacist...

    Authors: Eeman Mohammed, Saval Khanal, Zahraa Jalal, Ejaz Cheema, Mohammed H. Abutaleb and Vibhu Paudyal

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:25

    Content type: Research

    Published on:

  26. Minor ailments are defined as common, self-limiting, or uncomplicated conditions that may be diagnosed and managed without a medical intervention. Previous studies reported that pharmacists were able to help p...

    Authors: Mei Mei Tew, Ernieda Hatah, Faiz Arif, Muhammad Aqiff Abdul Wahid, Mohd Makmor-Bakry and Khairul Nizam Abdul Maulad

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:24

    Content type: Research

    Published on:

  27. The sustainable development goals were launched by the United Nations in 2015. Its fifth goal was describing the achievement of universal health coverage by 2030. This goal reaffirms the importance of investin...

    Authors: Banan Abdulrzaq Mukhalalati, Meram Mohamed Mahmoud Elsayed Ibrahim, Majdoleen Omar Al Alawneh, Ahmed Awaisu, Ian Bates and Lina Bader

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:22

    Content type: Research

    Published on:

  28. Achieving universal health coverage will require robust private sector engagement; however, as many low- and middle-income countries launch prepayment schemes to achieve universal health coverage, few are cove...

    Authors: Martha Embrey, Romuald Mbwasi, Elizabeth Shekalaghe, Jafary Liana, Suleiman Kimatta, Gasto Ignace, Angel Dillip and Tamara Hafner

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:21

    Content type: Research

    Published on:

  29. Inventory management is the heart of the supply system in improving availability of medicines, reducing the cost, and improving patient care quality. However, in the government facilities’ supply system, inven...

    Authors: Oliyad Kebede and Gizachew Tilahun

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:20

    Content type: Research

    Published on:

  30. Clostridium difficile infection (CDI) is responsible for 15–25% cases of health-care-associated diarrhea. The CDI treatment algorithm used at our hospital is adapted from the Infectious Diseases Society of Americ...

    Authors: Ali Elbeddini and Rachel Gerochi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:19

    Content type: Research

    Published on:

  31. To strengthen medicines management capacity, including supply chain management, at public sector health facilities in Uganda, the Ministry of Health introduced a multipronged supervision, performance assessmen...

    Authors: Denis Okidi Ladwar, Moses Nixon Sembatya, Nancy Miriam Amony, Morries Seru, Dennis Ross-Degnan, Laura Garabedian and Birna Trap

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:14

    Content type: Research

    Published on:

  32. Emergency department (ED) visits for high blood pressure are on the rise. Yet the majority of these patients are discharged home after their ED evaluation, particularly those who present following an elevated ...

    Authors: Ivona Mostarac and Clare L. Atzema

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:13

    Content type: Research

    Published on:

  33. The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and bes...

    Authors: Sabine Vogler, Nina Zimmermann, Zaheer-Ud-Din Babar, Reinhard Busse, Jaime Espin, Aukje K. Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:18

    Content type: Commentary

    Published on:

  34. European countries face fiscal pressure regarding the long-term sustainability of their healthcare system due to increasing levels of public health expenditures and mounting demographic pressures. The promotio...

    Authors: Lisa Aufegger, Celine Yanar, Ara Darzi and Colin Bicknell

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:11

    Content type: Research

    Published on:

  35. The COVID-19 pandemic has resulted in massive disruptions in global supply chains. Nigeria is particularly vulnerable with respect to pharmaceuticals since there is reduced local production and about 70% of th...

    Authors: Edward Faiva, Hashim Talib Hashim, Mustafa Ahmed Ramadhan, Shingin Kovona Musa, John Bchara, Yahya Dheyaa Tuama, Yusuff Adebayo Adebisi, Mustafa Hayder Kadhim, Mohammad Yasir Essar, Shoaib Ahmad and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:17

    Content type: Commentary

    Published on:

  36. Well-functioning national regulatory authorities (NRAs) ensure access to safe, effective, quality-assured, and affordable medical products. However, the benefits of their work are often unseen and difficult to...

    Authors: Gloria Twesigye, Tamara Hafner and Javier Guzman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:16

    Content type: Commentary

    Published on:

  37. COVID-19 is a threat to health systems around the world and Rwanda is not an exception. The impact of the pandemic is far-reaching and access to health commodities is not spared. Proper drug supply is critical...

    Authors: Theogene Uwizeyimana, Hashim Talib Hashim, Jean Damascene Kabakambira, Jean Claude Mujyarugamba, Jackson Dushime, Blaise Ntacyabukura, Remy Ndayizeye, Yusuff Adebayo Adebisi and Don Eliseo Lucero-Prisno III

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:12

    Content type: Commentary

    Published on:

  38. The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to...

    Authors: Ali Elbeddini, Sarah Almasalkhi, Thulasika Prabaharan, Cindy Tran, Mohamed Gazarin and Ahmed Elshahawi

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:10

    Content type: Research

    Published on:

  39. Antimicrobial agents are among the most commonly prescribed drugs in pregnancy due to the increased susceptibility to infections during pregnancy. Antimicrobials can contribute to different maternal complicati...

    Authors: Mohamed A. Baraka, Lina Hussain AlLehaibi, Hind Nasser AlSuwaidan, Duaa Alsulaiman, Md. Ashraful Islam, Badriyah Shadid Alotaibi, Amany Alboghdadly, Ali H. Homoud, Fuad H. Al-Ghamdi, Mastour S. Al Ghamdi and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:9

    Content type: Research

    Published on:

  40. Research has shown that there is an increase in the global prevalence of asthma. Pharmacists are well positioned to screen and refer patients for better management of asthma. This study aimed to evaluate commu...

    Authors: Sanah Hasan, Lujain Al Oum and Nageeb AbdulGalil Hassan

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:8

    Content type: Research

    Published on:

  41. The pharmaceutical technology unit of the Geneva University Hospitals played a significant role in the fight against COVID-19 through four different missions: (1) providing enough hydroalcoholic solution at th...

    Authors: Alexandra Garnier, Ludivine Falaschi, Pascal Bonnabry and Lucie Bouchoud

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:7

    Content type: Letter to the editor

    Published on:

  42. Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have the...

    Authors: Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim and Aidan Hollis

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:3

    Content type: Research

    Published on:

  43. Acute bronchiolitis is the leading cause of hospitalization in the pediatric population. The inappropriate prescription of antibiotics in acute bronchiolitis is associated with bacterial resistance, higher cos...

    Authors: Jefferson Antonio Buendía and John Edwin Feliciano-Alfonso

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:2

    Content type: Research

    Published on:

  44. The coronavirus disease 19 (COVID-19) pandemic is putting a huge strain on healthcare systems and is a turning point for the beginning of a global health crisis of an unprecedented condition. As such, the prov...

    Authors: Gemmechu Hasen, Rashed Edris, Gadisa Chala, Yesuneh Tefera, Hawi Hussen, Tamirat Tekassa and Sultan Suleman

    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:1

    Content type: Commentary

    Published on:

Annual Journal Metrics